文献速递垂体与肾上腺疾病糖尿病

库欣综合征与神经内分泌肿瘤患者更差生存及更高并发症相关

Cushing Syndrome Is Associated with Worse Survival and Higher Morbidity in Neuroendocrine Neoplasms.
PubMed 文献 · J Clin Endocrinol Metab · 2026-07-23

该回顾性队列研究基于TriNetX全球数据库,纳入105854例成人神经内分泌肿瘤患者,其中265例为符合异位库欣综合征(ECS)的编码定义库欣综合征。经1:1倾向评分匹配后比较264对患者,发现ECS与显著降低的总生存(8年生存率55.3% vs 71.2%;HR 1.848,95%CI 1.348-2.534;P<0.001)及更高的住院、严重感染、静脉血栓栓塞、代谢并发症和器官衰竭风险相关,但未观察到转移进展显著增加。

要点

  • 神经内分泌肿瘤患者中,符合ECS的库欣综合征与总生存显著降低相关(HR 1.848)。
  • ECS患者住院、严重感染、静脉血栓栓塞、代谢并发症及器官衰竭风险显著增加。
  • ECS患者的生存劣势主要反映高皮质醇血症相关并发症,而非肿瘤转移进展。

核心结论

  • 符合ECS的库欣综合征与神经内分泌肿瘤患者更差的总生存和显著更高的并发症风险相关,主要反映高皮质醇血症相关并发症而非肿瘤进展。

研究设计与样本

  • 回顾性队列研究,采用1:1倾向评分匹配,数据来自TriNetX全球协作网络的电子病历。
  • 纳入成人(≥18岁)神经内分泌肿瘤患者105854例,其中符合ECS的库欣综合征队列265例;匹配后比较264例ECS患者与264例无库欣综合征记录的患者。

主要发现

  • ECS与显著降低的总生存相关(8年生存率55.3% vs 71.2%;HR 1.848,95%CI 1.348-2.534;P<0.001)。
  • ECS患者住院、严重感染、静脉血栓栓塞、代谢并发症(高血压、糖尿病、低钾血症)及器官衰竭(肾衰竭和肝衰竭)风险增加。
  • 未观察到转移进展显著增加。

临床怎么用

  • 对神经内分泌肿瘤患者应早期识别高皮质醇血症,并积极治疗以改善结局。
  • 关注ECS患者的高皮质醇血症相关并发症,如感染、血栓、代谢紊乱和器官衰竭。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Ectopic Cushing syndrome (ECS) is a severe paraneoplastic complication of neuroendocrine neoplasms (NENs), but its association with survival and clinically relevant outcomes remains insufficiently defined in matched real-world cohorts. OBJECTIVE: To assess the association of code-defined Cushing syndrome compatible with ECS with OS and clinical outcomes in patients with NENs using a large propensity score-matched cohort. DESIGN: Retrospective cohort study with 1:1 propensity score matching. SETTING: Electronic medical records from TriNetX Global Collaborative Network, a federated database aggregating clinical data from international healthcare organizations. PATIENTS: Adult patients (≥18 years) with NEN (n = 105,854), including 265 in the ECS-compatible cohort. After matching, 264 patients in the ECS-compatible cohort were compared with 264 patients without documented Cushing syndrome. MAIN OUTCOME MEASURES: Primary outcome was OS. Secondary outcomes included hospitalization, emergency care use, severe infections, venous thromboembolism, metabolic complications, organ failure, and metastatic progression. RESULTS: ECS was associated with significantly reduced OS compared with non-ECS patients (8-year survival: 55.3% vs 71.2%; hazard ratio [HR] 1.848 [95% confidence interval 1.348-2.534]; P < 0.001). ECS patients had increased risks of hospitalization, severe infections, venous thromboembolism, and metabolic complications including hypertension, diabetes mellitus, and hypokalemia, as well as organ failure (kidney and liver failure). No significant increase in metastatic progression was observed. CONCLUSIONS: ECS-compatible Cushing syndrome was associated with worse survival and substantially higher morbidity in patients with NENs, mainly reflected by hypercortisolism-related complications rather than tumor progression. Early recognition and treatment of hypercortisolism may be critical to improve outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kappenstein M, Hamm AF, Lehmler E, et al. Cushing Syndrome Is Associated with Worse Survival and Higher Morbidity in Neuroendocrine Neoplasms. J Clin Endocrinol Metab. 2026. PMID: 42489135. doi:10.1210/clinem/dgag294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。